Quarterly Transactions Made in Cerevel Therapeutics Holdings, Inc. (CERE)
This table provides information about the institutional ownership of Cerevel Therapeutics Holdings, Inc. (CERE). The information is specifically focused on institutions that hold shares of Cerevel Therapeutics Holdings, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 19,959,185 | 1,518,392 | 21,477,577 | 1,464,900 | 4,164,081 | 5,628,981 | 15,848,596 | |
Q4 2021 | 1,917,647 | 1,065,390 | 2,983,037 | 2,572,025 | 501,738 | 3,073,763 | -90,726 | |
Q1 2022 | 3,896,660 | 2,224,553 | 6,121,213 | 2,366,170 | 935,030 | 3,301,200 | 2,820,013 | |
Q2 2022 | 3,490,066 | 941,153 | 4,431,219 | 2,097,351 | 329,845 | 2,427,196 | 2,004,023 | |
Q3 2022 | 9,811,633 | 3,404,600 | 13,216,233 | 2,119,807 | 10,465 | 2,130,272 | 11,085,961 | |
Q4 2022 | 2,516,977 | 2,449,831 | 4,966,808 | 2,052,206 | 0 | 2,052,206 | 2,914,602 | |
Q1 2023 | 2,363,350 | 4,444,391 | 6,807,741 | 4,422,975 | 0 | 4,422,975 | 2,384,766 | |
Q2 2023 | 6,428,459 | 1,637,237 | 8,065,696 | 6,201,901 | 0 | 6,201,901 | 1,863,795 | |
Q3 2023 | 4,302,654 | 2,497,157 | 6,799,811 | 2,842,866 | 73,843 | 2,916,709 | 3,883,102 | |
Q4 2023 | 23,147,806 | 20,443,513 | 43,591,319 | 22,992,889 | 0 | 22,992,889 | 20,598,430 | |
Q1 2024 | 13,333,981 | 6,589,208 | 19,923,189 | 15,556,252 | 0 | 15,556,252 | 4,366,937 | |
Q2 2024 | 9,191,818 | 5,690,930 | 14,882,748 | 11,909,113 | 0 | 11,909,113 | 2,973,635 | |
Q3 2024 | 7 | 0 | 7 | — | 7 |